Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin Chemoprevention of Oral Premalignant Lesions

NCT05536037 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT05536037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05536037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin Chemoprevention of Oral Premalignant Lesions
Lead sponsor
Thomas Jefferson University
Phase
Phase 1
Overall status
Terminated
Start date
May 4, 2022
Completion date
March 16, 2024
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythroplakia, leukoplakia, oral cavity carcinoma, proliferative verrucous leukoplakia